FIELD: medicine.
SUBSTANCE: pharmaceutical composition in the form of gel for treating metabolic involvements of ocular tissues contains synthetic carnosine, a preserving agent, hyaluronic acid as a gelling agent and water. The preserving agent is presented by the components specified in a group of: boric acid, polyhexanide, chlorhexidine, cetylpyridinium chloride. The components are used in the declared ratio, wt %: Additionally, the pharmaceutical composition contains the components specified in a group of: carbomer, macrogol 400, povidone.
EFFECT: using the invention enables providing the higher therapeutic effectiveness of the ophthalmic gel and ensuring prolonged action on the cornea.
2 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
EYE DROPS | 2012 |
|
RU2504372C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING EYE DISEASES RELATED TO EYE TISSUE METABOLIC DISEASE AND INFLAMMATORY EYE TISSUE INJURY | 2013 |
|
RU2521337C1 |
OPHTHALMIC GEL COMPOSITION FOR TREATING CONJUNCTIVITIS, BLEPHARITIS, KERATITIS CORNEAL EROSION ASSOCIATED WITH INFLAMMATORY EYE DISEASES OF NON-INFECTIOUS OR POST-INFECTIOUS ETIOLOGY AND ALLERGIC LESIONS OF OCULAR SURFACE | 2014 |
|
RU2582284C1 |
GEL-LIKE EYE DROPS FOR TREATMENT OF INFLAMMATORY ALLERGIC, BACTERIAL, VIRAL, TRAUMATIC AND DYSTROPHIC EYE DISEASES | 2014 |
|
RU2561046C1 |
OPHTHALMIC COMPOSITION OF EYE DROPS FOR TREATING ANTIBIOTIC-RESISTANT INFECTIOUS-INFLAMMATORY EYE DISEASES | 2014 |
|
RU2561048C1 |
EYE GEL DROPS FOR TREATMENT OF INFLAMMATORY, VIRUS, BACTERIAL, ALLERGIC, METABOLIC, TRAUMATIC DISEASES | 2017 |
|
RU2688687C1 |
GEL-LIKE ARTIFICIAL TEARS WITH ANTISEPTIC AND REPARATIVE ACTION | 2018 |
|
RU2679319C1 |
EYE GEL DROPS FOR TREATING ACUTE AND CHRONIC INFLAMMATORY EYE DISEASES CAUSED BY VIRAL, BACTERIAL, ALLERGIC, METABOLIC OR TRAUMATIC FACTORS | 2018 |
|
RU2692087C1 |
OPHTHALMIC COMPOSITION OF EYE DROPS FOR TREATING ANTIBIOTIC-RESISTANT INFECTIOUS-INFLAMMATORY EYE DISEASES | 2014 |
|
RU2561049C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF EYE DROPS FOR PREVENTING AND TREATING ALLERGIC EYE DISEASES | 2013 |
|
RU2549472C1 |
Authors
Dates
2016-02-20—Published
2014-10-30—Filed